|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Department of Veterans Affairs |
|---|---|
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00007761 |
Purpose
Based on highly promising preliminary data, it is proposed to conduct a multi-site randomized controlled trial of a high-intensity ambulatory treatment program for bipolar disorder against standard office-based, physician-centered care. The major characteristics of this program are that it emphasizes (1) aggressive guideline-driven pharmacotherapy, (2) continuity of care with identified primary mental health nurse clinicians supported by psychiatrist back-up, and (3) patient education to improve treatment alliance and illness management skills.
| Condition | Intervention | Phase |
|---|---|---|
|
Bipolar Disorder |
Behavioral: Bipolar Disorder Program Behavioral: Usual (psychiatric) Care |
Phase III |
| Study Type: | Interventional |
| Study Design: | Control: Active Control |
| Official Title: | CSP #430 - Reducing The Efficacy-Effectiveness Gap In Bipolar Disorder |
| Estimated Enrollment: | 382 |
| Study Start Date: | July 1997 |
| Primary Completion Date: | December 2003 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Bipolar Disorder Program
|
Behavioral: Bipolar Disorder Program |
|
2: Active Comparator
Usual (psychiatric) Care
|
Behavioral: Usual (psychiatric) Care |
Primary Hypothesis: The primary hypotheses are that Bipolar Disease Program (BDP) intervention will significantly improve (1) manic and (2) depressive symptom scores, as well as Total Treatment Costs as compared to usual care of bipolar patients.
Secondary Hypothesis: Secondary hypotheses include significant improvement in BDP patients as compared to usual bipolar treatment care with respect to functional outcome, quality of life, intensity of somatotherapy, patient satisfaction, and provider attitudes.
Intervention: Usual (psychiatric) Care vs Bipolar Disorder Program
Primary Outcomes: The primary outcomes are: (1) Manic Symptom Score; (2) Depressive Symptom Score; and (3) Total Treatment Costs.
Study Abstract: Based on highly promising preliminary data, it is proposed to conduct a multi-site randomized controlled trial of a high-intensity ambulatory treatment program for bipolar disorder against standard office-based, physician-centered care. The major characteristics of this program are that it emphasizes (1) aggressive guideline-driven pharmacotherapy, (2) continuity of care with identified primary mental health nurse clinicians supported by psychiatrist back-up, and (3) patient education to improve treatment alliance and illness management skills.
Patients with bipolar disorder will be randomly assigned to either standard care or the high intensity ambulatory program for three years. Outcome variables will cover three distinct domains: disease-specific outcome (number, length, and severity of manic and depressive episodes), functional outcome (social and occupational role function and subjective quality of life), and total treatment costs (direct treatment costs and indirect costs of illness). Preliminary data indicate that these domains are related but not redundant. Each of these is relevant to patient well-being and to VHA management.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients with bipolar disorder. Index episode of manic, major depression or both requiring hospitalization on acute unit. At lease two hospitalizations, three or more months apart within the past 5 years.
Exclusion Criteria:
Contacts and Locations| United States, Arizona | |
| Southern Arizona VA Health Care System, Tucson | |
| Tucson, Arizona, United States, 85723 | |
| United States, California | |
| VA Palo Alto Health Care System | |
| Palo Alto, California, United States, 94304-1290 | |
| VA San Diego Healthcare System, San Diego | |
| San Diego, California, United States, 92161 | |
| VA Greater Los Angeles Healthcare System, West LA | |
| West Los Angeles, California, United States, 90073 | |
| United States, Colorado | |
| VA Eastern Colorado Health Care System, Denver | |
| Denver, Colorado, United States, 80220 | |
| United States, Connecticut | |
| VA Connecticut Health Care System (West Haven) | |
| West Haven, Connecticut, United States, 06516 | |
| United States, Georgia | |
| VA Medical Center, Augusta | |
| Augusta, Georgia, United States, 30904 | |
| United States, Illinois | |
| Edward Hines, Jr. VA Hospital | |
| Hines, Illinois, United States, 60141-5000 | |
| United States, Indiana | |
| Richard Roudebush VA Medical Center, Indianapolis | |
| Indianapolis, Indiana, United States, 46202-2884 | |
| United States, Massachusetts | |
| VA Boston Healthcare System, Brockton Campus | |
| Brockton, Massachusetts, United States, 02301 | |
| United States, Ohio | |
| VA Medical Center, Cleveland | |
| Cleveland, Ohio, United States, 44106 | |
| United States, Tennessee | |
| James H. Quillen VA Medical Center | |
| Mountain Home, Tennessee, United States, 37684 | |
| United States, Texas | |
| VA North Texas Health Care System, Dallas | |
| Dallas, Texas, United States, 75216 | |
| Study Chair: | Mark S Bauer, MD BA | VA Boston Healthcare System, Brockton Campus |
More Information
| Responsible Party: | Department of Veterans Affairs ( Bauer, Mark - Study Chair ) |
| Study ID Numbers: | 430 |
| Study First Received: | December 29, 2000 |
| Last Updated: | September 22, 2009 |
| ClinicalTrials.gov Identifier: | NCT00007761 History of Changes |
| Health Authority: | United States: Federal Government |
|
Bipolar Disease Program intervention |
|
Affective Disorders, Psychotic Mental Disorders Bipolar Disorder Mood Disorders |